Juxtarenal aortic aneurysms (JAAs) have been conventionally treated using open repair with excellent results. Recent approval of fenestrated stent grafts by the United States Food and Drug Administration has given patients with JAAs an alternative for repair. However, most of these procedures are still performed under general anesthesia, making some surgeons reluctant to offer repair to a subset of patients deemed too high risk for general anesthesia. We present three patients with JAAs at high surgical risk, including one patient with a ruptured aneurysm, who were successfully treated using a fenestrated stent graft under regional anesthesia. (J Vasc Surg 2017;65:1820-2.) 
HRSPs with JAAs had limited treatment options.
In April 2012, the United States Food and Drug Administration approved the use of Cook fenestrated stent grafts (Cook Medical, Bloomington, Ind) for treatment of patients with JAAs in the United States. 6, 7 Because of the potential complexity involved with implantation of fenestrated stent grafts during endovascular aneurysm repair (FEVAR), most of these procedures are performed under GA. The use of regional anesthesia (RA) during FEVAR implantation has been reported but not widely embraced. 6, 8 We present three HRSPs with JAAs that were successfully excluded using FEVAR under RA. The patients consented to publication. These three patients were deemed poor candidates for open repair and GA. However, they lived independently and sought treatment. Their aneurysms were successfully excluded with FEVAR under RA, and they discharged to home with no complications.
RA was established by spinal anesthesia at L2-3 (bupivacaine with dextrose, plus epinephrine) and epidural anesthesia before the two elective patients were taken to the operating room. RA in patient 2 was initiated in the operating room because she had a contained rJAA.
The three procedures were performed percutaneously and commenced with insertion of a 20F Check-Flo sheath (Cook Medical) in the right common femoral artery over a previously placed Lunderquist wire (Cook Medical) after systemic heparinization.
SOS catheters (AngioDynamics, Latham, NY), placed through punctured valves of the Check-Flo sheath, were used to precannulate both renal arteries in the first and third patients. Patient 2 had an atrophic right kidney that was not revascularized.
In each case, the fenestrated device was oriented extracorporeally, inserted via the left femoral artery, and deployed using 
DISCUSSION
During surgery, the body mounts a physiologic response to stress resulting in elevation in the heart rate, release of inflammatory agents, increased myocardial contractility, and activation of coagulation cascade. [9] [10] [11] In patients with history of CAD, such as our patients, these changes may cause plaque rupture that subsequently leads to cardiac events. Furthermore, studies have shown that pulmonary complications develop postoperatively in up to 40% of patients with severe COPD undergoing abdominal surgery under GA.
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Arozullah et al 16 reported that patients with severe COPD undergoing abdominal aortic aneurysm repair are at a higher risk of developing postoperative respiratory failure. Most of these complications are the result of the normal physiologic response to stress. This response, however, is far more attenuated in patients treated with RA than in those undergoing similar procedures under GA. 17 Other studies, including a meta-analysis of 30 trials, have shown a reduction in perioperative cardiac events in patients whose operations were performed under RA compared with GA. 18, 19 It is therefore logical that local or RA should be the preferred anesthetic whenever possible, especially in HRSPs. Local anesthesia should be favored over RA in case of rJAA. However, the challenge of keeping a patient cooperative during a lengthy FEVAR makes local anesthesia a less appealing choice. RA has a number of absolute and relative contraindications that are worth mentioning. These include patient refusal, infection at the injection site, coagulopathy, severe hypovolemia, severe aortic or mitral valve stenosis, sepsis, dementia, psychosis, emotional instability, and severe spinal deformity. 20 Patients with these conditions and those with demyelinating lesions, such as multiple sclerosis, are best repaired under GA. The indication to treat these patients was determined by the size of their aneurysms, their independent living status, and their stable comorbid conditions. Patients repaired electively were seen in the clinic on several occasions, carefully counseled about their increased surgical risks and options, but requested repair. The patient with an rJAA wanted the full extent of medical care offered.
CONCLUSIONS
Vascular surgeons are increasingly being called to care for more complex patients. The decision to intervene in these cases should only be reached after patients have . By using a 6-mm Â 16-mm Atrium iCAST stent graft (Maquet, Rastatt, Germany) on the left, we were able to preserve both branches of the left renal arteries, despite the early bifurcation, without compromising exclusion of the aneurysm. A 6-mm Â 22-mm Atrium iCAST stent graft was used for the right renal artery. When the superior mesenteric artery was stented, 7-mm or 8-mm Â 38-mm Atrium iCAST stent grafts were used, depending on the size of the target artery. gained clear understanding of surgical risks and the real possibility of deterioration of their comorbid conditions postoperatively. Even in the era of minimally invasive approaches, some HRSPs should not be offered surgery. When repair is deemed appropriate, however, the ability of these patients to survive the operation and have a meaningful life after surgery will depend on our ability to minimize procedurally related complications. FEVAR for treatment of JAA can be performed safely under RA. This approach should be considered and used whenever possible, especially in HRSPs to mitigate the risks associated with GA.
